Archive: 19/06/2012

Germ-line BRCA1/2 testing recommended in ovarian cancer

(HealthDay) -- Due to the potential survival and treatment response implications of BRCA mutation status, it is recommended that germ-line BRCA1/2 testing be offered to all women diagnosed with nonmucinous ovarian carcinoma, ...

Jun 19, 2012
popularity0 comments 0